Detalhe da pesquisa
1.
Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours.
Br J Cancer
; 128(10): 1906-1915, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871042
2.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kß/δ, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(11): 2257-2269, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247924